Author | Moraes, Emilly Caroline dos Santos | |
Author | Gonçalves, Remy Martins | |
Author | Silva, Luana Rocha da | |
Author | Mandacaru, Samuel Coelho | |
Author | Melo, Reynaldo Magalhães | |
Author | Quintanilha, Isaclaudia Azevedo | |
Author | Perales, Jonas | |
Author | Bozza, Fernando A. | |
Author | Souza, Thiago Moreno Lopes | |
Author | Faria Neto, Hugo Caire Castro | |
Author | Hotz, Eugenio D. | |
Author | Bozza, Patrícia T. | |
Author | Trugilho, Monique R. O. | |
Access date | 2022-08-18T15:07:41Z | |
Available date | 2022-08-18T15:07:41Z | |
Document date | 2022 | |
Citation | MORAES, Emilly Caroline dos Santos et al. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19. Frontiers in Cellular and Infection Microbiology, v. 12, Article 926352, p. 1 - 17, July 2022. | pt_BR |
ISSN | 2235-2988 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/54712 | |
Language | eng | pt_BR |
Publisher | Frontiers Media | pt_BR |
Rights | open access | |
Subject in Portuguese | SARS-CoV-2 | pt_BR |
Subject in Portuguese | Vesículas extracelulares | pt_BR |
Subject in Portuguese | Proteoma | pt_BR |
Subject in Portuguese | LC-MS/MS | pt_BR |
Subject in Portuguese | Plaquetas | pt_BR |
Subject in Portuguese | Fatores complementares | pt_BR |
Subject in Portuguese | Fator tecidual | pt_BR |
Title | Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19 | pt_BR |
Type | Article | |
DOI | 10.3389/fcimb.2022.926352 | |
Abstract | Background: Extracellular vesicles (EVs) are a valuable source of biomarkers and display
the pathophysiological status of various diseases. In COVID-19, EVs have been explored
in several studies for their ability to reflect molecular changes caused by SARS-CoV-2.
Here we provide insights into the roles of EVs in pathological processes associated with
the progression and severity of COVID-19.
Methods: In this study, we used a label-free shotgun proteomic approach to identify and
quantify alterations in EV protein abundance in severe COVID-19 patients. We isolated
plasma extracellular vesicles from healthy donors and patients with severe COVID-19 by
size exclusion chromatography (SEC). Then, flow cytometry was performed to assess the
origin of EVs and to investigate the presence of circulating procoagulant EVs in COVID-19
patients. A total protein extraction was performed, and samples were analyzed by nLCMS/
MS in a Q-Exactive HF-X. Finally, computational analysis was applied to signify
biological processes related to disease pathogenesis.
Results: We report significant changes in the proteome of EVs from patients with severe
COVID-19. Flow cytometry experiments indicated an increase in total circulating EVs and
with tissue factor (TF) dependent procoagulant activity. Differentially expressed proteins in
the disease groups were associated with complement and coagulation cascades, platelet
degranulation, and acute inflammatory response. Conclusions: The proteomic data reinforce the changes in the proteome of extracellular
vesicles from patients infected with SARS-CoV-2 and suggest a role for EVs in severe
COVID-19. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxicologia. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxicologia. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz.. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil.. | pt_BR |
Affilliation | Universidade de Brasília. Departamento de Biologia Celular. Laboratório de Química e Bioquímica de Proteínas e Laboratório de Biologia Gênica. Brasília, DF, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxicologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Instituto D`ÓR de Pesquisa e Educação. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz.. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Universidade Federal de Juiz de Fora. Departamento de Bioquímica. Laboratório de Imunotrombose. Juiz de Fora, MG, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxicologia. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil. | pt_BR |
Subject | Extracellular vesicles | pt_BR |
Subject | LC-MS/MS | pt_BR |
Subject | Proteome | pt_BR |
Subject | SARS-CoV-2 | pt_BR |
Subject | Platelets | pt_BR |
Subject | Complement factors | pt_BR |
Subject | Tissue factor | pt_BR |